Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMJ Open|March 23, 2019
Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trialOlivia Oxlade, Anete Trajman, Andrea Benedetti, et al.
Plastic Surgery (Oakville, Ont.)|September 1, 2023
Gender Equality in Plastic Surgery Training: A Canadian Nationwide Cross-sectional AnalysisHassan ElHawary, Ali Salimi, Peter Alam, et al.
Plos Medicine|July 28, 2025
Rapid molecular testing or chest X-ray or tuberculin skin testing for household contact assessment of tuberculosis infection: A cluster-randomized trialMenonli Adjobimey, Anete Trajman, Mayara Lisboa Bastos, et al.
Eclinicalmedicine|April 8, 2024
Sustainability and impact of an intervention to improve initiation of tuberculosis preventive treatment: results from a follow-up study of the ACT4 randomized trialDick Menzies, Joseph Obeng, Panji Hadisoemarto, et al.
The Lancet. Respiratory Medicine|March 29, 2024
High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trialRovina Ruslami, Federica Fregonese, Lika Apriani, et al.
The New England Journal of Medicine|August 2, 2018
Safety and Side Effects of Rifampin versus Isoniazid in ChildrenThierno Diallo, Menonli Adjobimey, Rovina Ruslami, et al.
The Lancet. Public Health|March 25, 2021
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trialOlivia Oxlade, Andrea Benedetti, Mênonli Adjobimey, et al.
The New England Journal of Medicine|August 2, 2018
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in AdultsDick Menzies, Menonli Adjobimey, Rovina Ruslami, et al.
Pageof 2